SVMPharma Logo
  • Home
  • Our Services
    • Real World Evidence
    • Oncology RWE
    • Global RWE
    • Additional Services
    • Technology
  • Resource Centre
  • About Us
  • Contact Us
Home / Real World Evidence and Adaptive Pathways

Real World Evidence and Adaptive Pathways

Real World Evidence & Adaptive Pathways Thumbnail

Posted in Blogs.

Post navigation

← SVMPharma’s RWE behind a successful…
SVMPharma at ISPOR Milan November 2015 →

Click here to subscribe to SVMPharma’s RWE updates

Latest Updates

  • SVMPharma’s unique access to cancer electronic prescribing records helps you get one step ahead of SACT
  • Answering real world clinical questions with Real World Data
  • Finding answers in the real world: NICE’s increasing usage of real world data
  • 97% of Companies to Increase Use of Real World Patient Data
  • 60% of pharma said data availability is the greatest challenge in RWE

Archives

  • August 2018 (1)
  • April 2018 (1)
  • March 2018 (2)
  • February 2018 (2)
  • January 2018 (1)
  • November 2017 (2)
  • October 2017 (2)
  • September 2017 (3)
  • August 2017 (2)
  • July 2017 (3)
  • June 2017 (2)
  • May 2017 (2)
  • April 2017 (2)
  • March 2017 (2)
  • February 2017 (2)
  • January 2017 (2)
  • December 2016 (1)
  • November 2016 (3)
  • October 2016 (3)
  • September 2016 (4)
  • August 2016 (2)
  • July 2016 (2)
  • June 2016 (5)
  • May 2016 (7)
  • April 2016 (4)
  • March 2016 (1)
  • February 2016 (2)
  • December 2015 (2)
  • November 2015 (3)
  • October 2015 (2)
  • September 2015 (1)
  • July 2015 (4)
  • June 2015 (2)
  • April 2015 (3)
  • March 2015 (3)
  • February 2015 (2)
  • January 2015 (1)

Quick Links

  • Real World Evidence
  • Global Real World Evidence
  • Additional Services
  • Technology
  • Privacy Policy
  • Contact Us

About SVMPharma

SVMPharma is a bespoke strategic consultancy based in Hampshire UK, specialising in Real World Evidence (RWE) for the pharmaceutical and healthcare industries. At SVMPharma we also cover Global RWE, Patient Experience, Big Data Analytics and Influence Mapping alongside Additional Services. Find further information and read our latest articles in the Resource Centre.

icon-phone +44 (0)1252 417030

Quick Links

  • Real World Evidence
  • Global Real World Evidence
  • Additional Services
  • Technology
  • Privacy Policy
  • Contact Us

Twitter

Tweets by @SVMPharma

RSS Latest News

  • Measles cases in Europe hit record high August 21, 2018
  • Pfizer’s lorlatinib clears first hurdle to UK early access scheme August 21, 2018
  • Novo’s oral semaglutide hits targets in diabetics with renal impairment August 21, 2018
  • NHS managers warn no-deal Brexit risks drug shortages August 21, 2018
  • US nod for Opdivo in pre-treated small cell lung cancer August 20, 2018
  • Privacy Policy
  • Website Disclaimer
  • Sitemap
© 2016 SVMPharma Ltd. All rights reserved.